Reuters logo
in 4 months
BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease
April 3, 2017 / 9:14 PM / in 4 months

BRIEF-Teva announces FDA approval of AUSTEDO tablets for treatment of chorea associated with huntington’s disease

1 Min Read

April 3 (Reuters) - Teva Pharmaceutical Industries Ltd -

* Teva announces FDA approval of AUSTEDO™ (deutetrabenazine) tablets for the treatment of chorea associated with huntington’s disease

* AUSTEDO is expected to be available in U.S. within next 3 weeks. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below